MannKind Corp (MNKD)
6.84
-0.06
(-0.87%)
USD |
NASDAQ |
Nov 22, 16:00
6.81
-0.03
(-0.44%)
After-Hours: 20:00
MannKind Price: 6.84 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 6.94 | 7.005 | 6.82 | 6.84 | 3.019M |
| Nov 21, 2024 | 6.89 | 6.98 | 6.74 | 6.90 | 3.629M |
| Nov 20, 2024 | 6.88 | 7.04 | 6.80 | 6.88 | 1.927M |
| Nov 19, 2024 | 6.68 | 6.87 | 6.67 | 6.86 | 1.715M |
| Nov 18, 2024 | 6.90 | 6.934 | 6.68 | 6.72 | 2.328M |
| Nov 15, 2024 | 7.05 | 7.07 | 6.62 | 6.80 | 5.216M |
| Nov 14, 2024 | 6.96 | 7.44 | 6.92 | 7.02 | 3.427M |
| Nov 13, 2024 | 7.12 | 7.25 | 6.935 | 6.96 | 2.416M |
| Nov 12, 2024 | 7.17 | 7.305 | 7.042 | 7.08 | 2.927M |
| Nov 11, 2024 | 7.45 | 7.48 | 7.15 | 7.22 | 3.628M |
| Nov 08, 2024 | 6.99 | 7.35 | 6.61 | 7.345 | 4.823M |
| Nov 07, 2024 | 7.50 | 7.62 | 7.39 | 7.39 | 3.972M |
| Nov 06, 2024 | 7.34 | 7.63 | 7.261 | 7.44 | 3.680M |
| Nov 05, 2024 | 7.02 | 7.30 | 7.01 | 7.26 | 1.769M |
| Nov 04, 2024 | 7.18 | 7.325 | 7.055 | 7.09 | 2.278M |
| Nov 01, 2024 | 7.16 | 7.30 | 7.10 | 7.17 | 2.469M |
| Oct 31, 2024 | 7.05 | 7.145 | 6.774 | 7.07 | 3.694M |
| Oct 30, 2024 | 6.91 | 7.14 | 6.825 | 7.02 | 3.163M |
| Oct 29, 2024 | 6.82 | 7.09 | 6.80 | 6.87 | 5.558M |
| Oct 28, 2024 | 6.58 | 6.90 | 6.565 | 6.82 | 2.440M |
| Oct 25, 2024 | 6.50 | 6.64 | 6.415 | 6.54 | 1.322M |
| Oct 24, 2024 | 6.47 | 6.51 | 6.305 | 6.44 | 1.585M |
| Oct 23, 2024 | 6.63 | 6.67 | 6.49 | 6.49 | 1.011M |
| Oct 22, 2024 | 6.56 | 6.719 | 6.56 | 6.64 | 935226.0 |
| Oct 21, 2024 | 6.57 | 6.67 | 6.545 | 6.62 | 1.659M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8415
Minimum
Mar 16 2020
7.44
Maximum
Nov 06 2024
3.802
Average
4.03
Median
May 13 2021
Price Benchmarks
| Mirum Pharmaceuticals Inc | 44.73 |
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.96 |
| iBio Inc | 2.64 |
| Theriva Biologics Inc | 1.28 |
Price Related Metrics
| PE Ratio | 85.50 |
| PS Ratio | 7.374 |
| Price to Free Cash Flow | 68.23 |
| Earnings Yield | 1.17% |
| Market Cap | 1.886B |
| Operating PE Ratio | 34.41 |
| Normalized PE Ratio | 67.28 |